The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Hydrogenics Corp

Nasdaq: HYGS
Last

(U.S.) $9.55

Today's change+0.79 +9.02%
Updated August 28 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Hydrogenics Corp

Nasdaq: HYGS
Last

(U.S.) $9.55

Today's change+0.79 +9.02%
Updated August 28 4:00 PM -4GMT. Delayed by at least 15 minutes.

Hydrogenics Corp Hits New 20-day High

Hydrogenics Corp closed up sharply Friday, rallying (U.S.)$0.79 or 9.02% to (U.S.)$9.55 and setting a new 20-day high. Over the last five days, shares have gained 27.67%, but are down 28.14% for the last year to date. Shares have underperformed the S&P 500 by 53.36% during the last year.

Key company metrics

  • Open(U.S.) $8.77
  • Previous close(U.S.) $8.76
  • High(U.S.) $9.72
  • Low(U.S.) $8.61
  • Bid / Ask-- / --
  • YTD % change-28.14%
  • Volume48,267
  • Average volume (10-day)39,571
  • Average volume (1-month)61,217
  • Average volume (3-month)47,539
  • 52-week range(U.S.) $7.32 to (U.S.) $22.53
  • Beta0.13
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.77
Updated August 28 4:00 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-18.67%

Hydrogenics Corp has a net profit margin of -18.67%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.71%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue781611
Total other revenue--------
Total revenue781611
Gross profit1133
Total cost of revenue66138
Total operating expense10101512
Selling / general / administrative3323
Research & development1101
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-3-20-1
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-4-31-1
Income after tax-4-31-1
Income tax, total0000
Net income-4-31-1
Total adjustments to net income--------
Net income before extra. items-4-31-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-31-1
Inc. avail. to common incl. extra. items-4-31-1
Diluted net income-4-31-1
Dilution adjustment--------
Diluted weighted average shares10101010
Diluted EPS excluding extraordinary itemsvalue per share-0.37-0.340.06-0.13
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.37-0.340.06-0.13